Abraham N. Oler - Nov 18, 2021 Form 4 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
SVP Corp Dev & Gen Counsel
Signature
/s/ Mark Guerin as attorney-in-fact
Stock symbol
ONTX
Transactions as of
Nov 18, 2021
Transactions value $
$15,000
Form type
4
Date filed
11/19/2021, 07:45 AM
Previous filing
Sep 29, 2021
Next filing
Nov 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONTX Common Stock Exercise of in-the-money or at-the-money derivative security $15K +5K +39.96% $3.00 17.5K Nov 18, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Warrant (right to purchase) Exercise of in-the-money or at-the-money derivative security $0 -5K -100% $0.00* 0 Nov 18, 2021 Common Stock 5K $3.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 9,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee.
F2 The warrants were acquired in the November 2019 public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant.